Cargando…

Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer

SIMPLE SUMMARY: Epigenetic processes contribute to the regulation of the immune system by activating multiple transcriptional changes, which in turn, are the product of immune cell reprogramming. Given that the deregulation of these mechanisms promotes cancer progression by altering the balance of g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conte, Mariarosaria, Di Mauro, Annabella, Capasso, Lucia, Montella, Liliana, De Simone, Mariacarla, Nebbioso, Angela, Altucci, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093005/ https://www.ncbi.nlm.nih.gov/pubmed/37046620 http://dx.doi.org/10.3390/cancers15071960

Ejemplares similares

Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy
por: Conte, Mariarosaria, et al.
Publicado: (2020)

Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New Targets
por: Santaniello, Giovanna, et al.
Publicado: (2022)

HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape
por: Conte, Mariarosaria, et al.
Publicado: (2014)

Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes
por: Nebbioso, Angela, et al.
Publicado: (2009)

SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism
por: Varghese, Benluvankar, et al.
Publicado: (2023)

HDAC2‐dependent miRNA signature in acute myeloid leukemia
por: Conte, Mariarosaria, et al.
Publicado: (2019)

Gene Transactivation and Transrepression in MYC-Driven Cancers
por: Scafuro, Marika, et al.
Publicado: (2021)

The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia
por: Di Costanzo, Antonella, et al.
Publicado: (2018)

Forskolin Sensitizes Human Acute Myeloid Leukemia Cells to H3K27me2/3 Demethylases GSKJ4 Inhibitor via Protein Kinase A
por: Illiano, Michela, et al.
Publicado: (2018)

HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b
por: Lepore, Ilaria, et al.
Publicado: (2013)

Relevance of AIF/CypA Lethal Pathway in SH-SY5Y Cells Treated with Staurosporine
por: Conte, Mariarosaria, et al.
Publicado: (2021)

The KDM Inhibitor GSKJ4 Triggers CREB Downregulation via a Protein Kinase A and Proteasome-Dependent Mechanism in Human Acute Myeloid Leukemia Cells
por: Illiano, Michela, et al.
Publicado: (2020)

KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches
por: Varghese, Benluvankar, et al.
Publicado: (2021)

Sirtuins and Disease: The Road Ahead
por: Carafa, Vincenzo, et al.
Publicado: (2012)

Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype
por: Carafa, Vincenzo, et al.
Publicado: (2019)

DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment
por: Sarno, Federica, et al.
Publicado: (2019)

Cytotoxic Potential of the Marine Diatom Thalassiosira rotula: Insights into Bioactivity of 24-Methylene Cholesterol
por: Cutignano, Adele, et al.
Publicado: (2022)

SIRT1 Activation by Natural Phytochemicals: An Overview
por: Iside, Concetta, et al.
Publicado: (2020)

CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway
por: Del Gaudio, Nunzio, et al.
Publicado: (2022)

Sirtuin Inhibitor Cambinol Induces Cell Differentiation and Differently Interferes with SIRT1 and 2 at the Substrate Binding Site
por: Giordano, Deborah, et al.
Publicado: (2023)

Cancer epigenetics: Moving forward
por: Nebbioso, Angela, et al.
Publicado: (2018)

Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses
por: Nebbioso, Angela, et al.
Publicado: (2017)

The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic Options
por: Di Costanzo, Antonella, et al.
Publicado: (2020)

Molecular Docking Simulations on Histone Deacetylases (HDAC)-1 and -2 to Investigate the Flavone Binding
por: Scafuri, Bernardina, et al.
Publicado: (2020)

HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
por: Roca, Maria Serena, et al.
Publicado: (2022)

Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome
por: Pancione, Massimo, et al.
Publicado: (2010)

Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
por: Roca, Maria Serena, et al.
Publicado: (2022)

Correction: Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome
por: Pancione, Massimo, et al.
Publicado: (2011)

BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition
por: Del Gaudio, Nunzio, et al.
Publicado: (2019)

HDAC6 Inhibition Extinguishes Autophagy in Cancer: Recent Insights
por: Passaro, Eugenia, et al.
Publicado: (2021)

Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
por: Verdina, Alessandra, et al.
Publicado: (2008)

Histone deacetylase inhibitors: clinical implications for hematological malignancies
por: Tambaro, Francesco Paolo, et al.
Publicado: (2010)

The Role of Necroptosis: Biological Relevance and Its Involvement in Cancer
por: Della Torre, Laura, et al.
Publicado: (2021)

Retraction Note: Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
por: Verdina, Alessandra, et al.
Publicado: (2022)

Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
por: Marchini, Antonio, et al.
Publicado: (2016)

Antiproliferative, Antibacterial and Antifungal Activity of the Lichen Xanthoria parietina and Its Secondary Metabolite Parietin
por: Basile, Adriana, et al.
Publicado: (2015)

3-Chloro-N′-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
por: Sarno, Federica, et al.
Publicado: (2018)

Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation
por: Bilancio, Antonio, et al.
Publicado: (2017)

Trifolium Repens Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway
por: Sarno, Federica, et al.
Publicado: (2020)

Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma
por: Lee, Dae-Hee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l02g1pgkcnt3ggek7cfcdmistd